Sonic (ASX:SHL) share price hits all-time high today
Shares in the global pathology provider are scaling new heights.
Multi Asset Portfolio Strategist at Zecca Capital Partners
Zach is a hedge fund analyst with an extensive background in equities and portfolio management. Alongside contributing to The Motley Fool, he works in portfolio strategy with a multi-asset and multi-strategy hedge fund manager. As such, he has a unique approach to research and investing, taking a top down approach to identifying unique value propositions that sit within his circle of competence. Zach enjoys the more Foolish things in life, in addition to Rugby.
Investors with cash may want to consider some ASX shares that have longer-term growth potential.
The below two businesses have grown considerably over the last two years, but they may have more growth potential over the coming years:
Sonic is a large, global business that’s involved in pathology, diagnostic imaging and radiology as well as general practice medicine and corporate medical services.
In the first half of FY21, it saw elevated revenue growth of 33% to $4.4 billion. Profit measures grew even faster. Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 89% to $1.3 billion and net profit increased 166% to $678 million. This profit growth occurred thanks to the operating leverage of using existing facilities.
ASX 200 drops, Sonic acquires, Challenger down on Thursday 17 June 2021 fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.
These 3 ASX shares keep growing their dividends for shareholders, including record-holder Washington H. Soul Pattinson and Co. Ltd (ASX:SOL). The post 3 ASX shares that keep growing their dividends every year appeared first on The Motley Fool Australia.
2 ASX 200 COVID-19 shares to buy
Tristan Harrison | May 10, 2021 1:13pm |
More on:
There are a few
S&P/ASX 200 Index (ASX: XJO) shares that are seeing a lot of growth despite, or because of, the COVID-19 pandemic.
However, the below two global businesses have been generating long-term growth and expect growth after the pandemic subsides:
Sonic is one of the biggest healthcare shares on the ASX. It is a major pathology business with laboratories all around the world.
It’s currently operating in Australia, Belgium, Switzerland, the UK, Germany, the USA, Ireland and New Zealand.
Sonic’s COVID testing capability continues to play an important part in controlling the control. How important? At the time of its FY21 half-year result release, it had done over 18 million COVID PCR tests across the world.